References
1. Woof JM, Burton DR. Human antibody–Fc receptor interactions illuminated by crystal structures. Nat. Rev. Immunol. 2004; https://doi.org/10.1038/nri1266
2. Ito T, Nishi H, Kameda T, Yoshida M, Fukazawa R, Kawada S, et al. Combination Informatic and Experimental Approach for Selecting Scaffold Proteins for Development as Antibody Mimetics. Chem. Lett. 2021; https://doi.org/10.1246/cl.210443
3. Kang TH, Seong BL. Solubility, stability, and avidity of recombinant antibody fragments expressed in microorganisms. Front. Microbiol. 2020; https://doi.org/10.3389/fmicb.2020.01927
4. Kadonosono T, Yimchuen W, Ota Y, See K, Furuta T, Shiozawa T, et al. Design strategy to create antibody mimetics harbouring immobilised complementarity determining region peptides for practical use. Sci. Rep. 2020; https://doi.org/10.1038/s41598-020-57713-4
5. Chiu ML, Goulet DR, Teplyakov A, Gilliland GL. Antibody structure and function: the basis for engineering therapeutics. Antibodies. 2019; https://doi.org/10.3390/antib8040055
6. Nicaise M, Valerio‐Lepiniec M, Minard P, Desmadril M. Affinity transfer by CDR grafting on a non-immunoglobulin scaffold. Protein Sci. 2004; https://doi.org/10.1110/ps.03540504
7. Löfblom J, Frejd FY. Alternative scaffolds as bispecific antibody mimetics. In: Bispecific antibodies. Springer. 2011; https://doi.org/10.1007/978-3-642-20910-9_7
8. Garg P. Selective Preference of Antibody Mimetics over Antibody, as Binding Molecules, for Diagnostic and Therapeutic Applications in Cancer Therapy. Biointerface Res Appl Chem. 2021; https://doi.org/10.33263/briac113.1067910689
9. Wagner HJ, Wehrle S, Weiss E, Cavallari M, Weber W. A two-step approach for the design and generation of nanobodies. Int J Mol Sci. 2018; https://doi.org/10.3390/ijms19113444
10. Liberis E, Veličković P, Sormanni P, Vendruscolo M, Liò P. Parapred: antibody paratope prediction using convolutional and recurrent neural networks. Bioinformatics. 2018; https://doi.org/10.1093/bioinformatics/bty305
11. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007; https://doi.org/10.1093/nar/gkm290
12. Van Zundert G, Rodrigues J, Trellet M, Schmitz C, Kastritis P, Karaca E, et al. The HADDOCK2. 2 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 2016; https://doi.org/10.1016/j.jmb.2015.09.014
13. Mathpal S, Joshi T, Sharma P, Joshi T, Pundir H, Pande V, et al. A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor. J. Biomol. Strut. Dyn. 2022; https://doi.org/10.1080/07391102.2020.1821785
14. Hess B, Kutzner C, Van Der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008; https://doi.org/10.1021/ct700301q
15. Kuzmanic A, Zagrovic B. Determination of ensemble-average pairwise root-mean-square deviation from experimental B-factors. Biophys J. 2010; https://doi.org/10.1016/j.bpj.2009.11.011
16. Chen D, Oezguen N, Urvil P, Ferguson C, Dann SM, Savidge TC. Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv. 2016; https://doi.org/10.1126/sciadv.1501240
17. DeLano WL. The PyMOL molecular graphics system. http://www pymol org. 20.
18. Richards DA. Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery. Drug Discov Today Technol. 2018; https://doi.org/10.1016/j.ddtec.2018.10.005
19. Sickmier EA, Kurzeja RJ, Michelsen K, Vazir M, Yang E, Tasker AS. The panitumumab EGFR complex reveals a binding mechanism that overcomes cetuximab-induced resistance. PloS one. 2016; https://doi.org/10.1371/journal.pone.0163366
20. Martin-Fernandez ML, Clarke DT, Roberts SK, Zanetti-Domingues LC, Gervasio FL. Structure and dynamics of the EGF receptor as revealed by experiments and simulations and its relevance to non-small cell lung cancer. Cells. 2019; https://doi.org/10.3390/cells8040316
21. Voigt M, Braig F, Göthel M, Schulte A, Lamszus K, Bokemeyer C, et al. Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab. Neoplasia. 2012; https://doi.org/10.1593/neo.121242